Skip to main content
Site Logo

Download QR

Open Free Demat Account!

Join Our 9 Lakh Customers

+91
Headphone
HomeStocksMankind Pharma Ltd
Mankind Pharma Ltd

Mankind Pharma Ltd

Symbol:MANKIND
Mid Cap
LTP2238.4
-26.6 (-1.17%)
No chart data available for selected period

Fundamentals Ratios

Key Valuation Metrics

Market Cap₹93,596.02 Cr
P/E Ratio45.27
P/B Ratio5.71
Industry Ratio38.26
ROE11.74%
EPS (TTM)₹50.06
Dividend Yield0.04%
Book Value₹396.98
Face Value₹1
Sector P/E38.26
Outstanding Shares41.30 Cr
Beta0.74
Market Cap Type- -

Financial Statements

ParticularsMAR 2025MAR 2024MAR 2023MAR 2022
Sales Turnover12,207.4410,260.448,749.437,781.56
Other Income553.56296.41140.99210.48
Total Revenue12,94410,651.538,601.238,441.63
Total Expenditure9,369.977,839.956,558.316,240.6
Operating Profit3,574.032,811.582,042.922,201.02
Interest431.9534.2445.7659.8
Gross Profit3,142.082,777.341,997.162,141.22
Depreciation621.22378.42325.92166.62
Profit Before Tax2,520.862,398.921,671.241,974.6
Tax596.04492.51327.56469.03
Net Profit2,011.121,941.771,309.681,452.96

About

Managing Director- -
Auditor NameS R Batliboi & Co LLP/Bhagi Bhardwaj Gaur & Co
Founded1991
Parent OrganizationMankind Pharma Ltd

Price Summary

Open

₹2,260

Prev Close

₹2,265

Today's High

₹2,276.5

Today's Low

₹2,235.1

52W High₹2,674
52W Low₹1,909.7
Volume1,80,515
Traded ValueN/A

Shareholding Pattern

Foreign Promoters and Groups
Indian Promoters and Groups
Non-Promoter Institutions
Non-Promoter Non-Institutions

Data as per latest exchange filings*

Frequently Asked Questions

Common questions about this stock, answered from live data

As of 10 Sept 2026, 3:30 pm, the share price of Mankind Pharma Ltd (MANKIND) is ₹2,238.4 on NSE and BSE.

Disclaimer: The FAQs above are generated based on historical and real-time market data provided by exchanges. This information is for educational purposes only and does not constitute financial advice, buy/sell recommendations, or price targets. Investment in the securities market is subject to market risks. Read all related documents carefully before investing.